Xtant Medical Holdings Inc (XTNT) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Xtant Medical Holdings Inc. faces a significant business risk due to the potential distribution of shares by funds affiliated with OrbiMed, which own approximately 53% of the company’s outstanding common stock. Given the limited investment time frames typical for such funds, there is a possibility that ROS and Royalty Opportunities may opt to distribute their shares to limited partners if alternative liquidity options are unavailable. This distribution could severely impact Xtant’s stock price, considering the company’s historical trading volumes and low public float, potentially leading to delisting proceedings by NYSE American if the stock price becomes abnormally low. Such events could have a substantial adverse effect on the company’s market presence and investor confidence.
The average XTNT stock price target is $2.00, implying 333.65% upside potential.
To learn more about Xtant Medical Holdings Inc’s risk factors, click here.